IIRM Holdings India Regulatory Approval

Board Meeting Date

IIRM Holdings India Board Meeting Date

IIRM Holdings India Ltd scheduled its Board of Directors meeting for 12 Nov 2026 to approve Q2/H1 results. The trading window is closed pending the outcome.

Other Announcement

IIRM Holdings India Other Announcement

IIRM Holdings India Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026, as per regulatory requirements.

Capital Structure Change

IIRM Holdings India Capital Structure Change

IIRM Holdings received trading approval for 15.6 lakh equity shares issued to non-promoter investors on a preferential basis. The shares are listed effective October 9, 2026.

Value

₹22.35 Cr

Capital Structure Change

IIRM Holdings India Capital Structure Change

IIRM Holdings India Ltd filed this shareholding pattern following the allotment of equity shares and convertible warrants through a preferential issue.

Other Announcement

IIRM Holdings India Other Announcement

Carpediem Capital Partners Fund II acquired 11,67,295 equity shares and 66,14,671 convertible warrants in IIRM Holdings via preferential allotment. The non-promoter investor now holds 11.15% of voting capital.

Capital Structure Change

IIRM Holdings India Capital Structure Change

IIRM Holdings allotted 15.60 lakh equity shares and 88.39 lakh convertible warrants at Rs. 143.28 each, aggregating to Rs. 149 Crore via a preferential issue.

Value

₹149.0 Cr

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.